Low fermentable, oligo-, di-, mono-saccharides and polyol diet in the treatment of irritable bowel syndrome: A systematic review and meta-analysis

Canavan, 2014, The epidemiology of irritable bowel syndrome, Clin Epidemiol, 6, 71 Drossman, 2016, Functional gastrointestinal disorders: History, pathophysiology, clinical features and Rome IV, Gastroenterology, 150, 1262, 10.1053/j.gastro.2016.02.032 Eswaran, 2011, Food: The forgotten factor in the irritable bowel syndrome, Gastroenterol Clin North Am, 40, 141, 10.1016/j.gtc.2010.12.012 Barrett, 2010, Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon, Aliment Pharmacol Ther, 31, 874 Halmos, 2015, Diets that differ in their FODMAP content alter the colonic luminal microenvironment, Gut, 64, 93, 10.1136/gutjnl-2014-307264 Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement, PLoS Med, 6, e1000097, 10.1371/journal.pmed.1000097 Cochrane Handbook for Systematic Reviews of interventions. Available at: http://training.cochrane.org/handbook. Accessed November 7, 2011. Drossman, 2006, Rome III: New standard for functional gastrointestinal disorders, J Gastrointestin Liver Dis, 15, 237 Francis, 1997, The irritable bowel severity scoring system: A simple method of monitoring irritable bowel syndrome and its progress, Aliment Pharmacol Ther, 11, 395, 10.1046/j.1365-2036.1997.142318000.x Ware, 2000 Patrick, 1998, Quality of life in persons with irritable bowel syndrome: Development and validation of a new measure, Dig Dis Sci, 43, 400, 10.1023/A:1018831127942 Zigmond, 1983, The hospital anxiety and depression scale, Acta Psychiatr Scand, 67, 361, 10.1111/j.1600-0447.1983.tb09716.x Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 Biesiekierski, 2013, No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates, Gastroenterology, 145, 320, 10.1053/j.gastro.2013.04.051 Bohn, 2015, Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: A randomized controlled trial, Gastroenterology, 149, 1399, 10.1053/j.gastro.2015.07.054 Chumpitazi, 2015, Randomised clinical trial: Gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome, Aliment Pharmacol Ther, 42, 418, 10.1111/apt.13286 Halmos, 2014, A diet low in FODMAPs reduces symptoms of irritable bowel syndrome, Gastroenterology, 146, 67, 10.1053/j.gastro.2013.09.046 McIntosh, 2017, FODMAPs alter symptoms and the metabolome of patients with IBS: A randomised controlled trial, Gut, 66, 1241, 10.1136/gutjnl-2015-311339 Pedersen, 2014, Ehealth: Low FODMAP diet vs lactobacillus rhamnosus GG in irritable bowel syndrome, World J Gastroenterol, 20, 16215, 10.3748/wjg.v20.i43.16215 Staudacher, 2012, Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome, J Nutr, 142, 1510, 10.3945/jn.112.159285 Staudacher, 2016, The low FODMAP diet reduces symptoms in irritable bowel syndrome compared with placebo diet and the microbiota alterations may be prevented by probiotic co-administration: A 2 x2 factorial randomized controlled trial, Gastroenterology, 150, S230, 10.1016/S0016-5085(16)30842-3 Harvie, 2013, A reduction in FODMAP intake correlates strongly with a reduction in IBS symptoms–the FIBS study, J Gastroenterol Hepatol, 28, 623 Eswaran, 2016, A randomized controlled trial Comparing the low FODMAP diet vs. modified NICE guidelines in US adults with IBS-D, Am J Gastroenterol, 111, 1824, 10.1038/ajg.2016.434 Ong, 2010, Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome, J Gastroenterol Hepatol, 25, 1366, 10.1111/j.1440-1746.2010.06370.x Gibson, 2012, Food choice as a key management strategy for functional gastrointestinal symptoms, Am J Gastroenterol, 107, 657, 10.1038/ajg.2012.49 Eswaran, 2013, Fiber and functional gastrointestinal disorders, Am J Gastroenterol, 108, 718, 10.1038/ajg.2013.63 Whitehead, 1992, Effects of stressful life events on bowel symptoms: Subjects with irritable bowel syndrome compared with subjects without bowel dysfunction, Gut, 33, 825, 10.1136/gut.33.6.825 Cole, 2006, Migraine, fibromyalgia, and depression among people with IBS: A prevalence study, BMC Gastroenterol, 6, 26, 10.1186/1471-230X-6-26 Rao, 2009, A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome, Gut Pathog, 1, 6, 10.1186/1757-4749-1-6 Aizawa, 2016, Possible association of bifidobacterium and lactobacillus in the gut microbiota of patients with major depressive disorder, J Affect Disord, 202, 254, 10.1016/j.jad.2016.05.038 Whelan, 2013, Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease, Curr Opin Gastroenterol, 29, 184, 10.1097/MOG.0b013e32835d7bba Wang, 2014, Are there any different effects of bifidobacterium, lactobacillus and streptococcus on intestinal sensation, barrier function and intestinal immunity in PI-IBS mouse model?, PLoS One, 9, e90153, 10.1371/journal.pone.0090153 Kerckhoffs, 2009, Lower bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients, World J Gastroenterol, 15, 2887, 10.3748/wjg.15.2887 Marsh, 2016, Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis, Eur J Nutr, 55, 897, 10.1007/s00394-015-0922-1 Mansueto, 2015, Role of FODMAPs in patients with irritable bowel syndrome, Nutr Clin Pract, 30, 665, 10.1177/0884533615569886 Kang, 2005, Systematic review: The influence of geography and ethnicity in irritable bowel syndrome, Aliment Pharmacol Ther, 21, 663, 10.1111/j.1365-2036.2005.02396.x Gartlehner, 2008, Assessment of adverse effects and applicability–two areas not (yet) covered adequately in Cochrane reports, Z Evid Fortbild Qual Gesundhwes, 102, 497, 10.1016/j.zefq.2008.08.028 Wu, 2011, Linking long-term dietary patterns with gut microbial enterotypes, Science, 334, 105, 10.1126/science.1208344 Miller, 2014, Study design considerations for irritable bowel syndrome clinical trials, Ann Gastroenterol, 27, 338 Schulz, 2010, CONSORT 2010 statement: Updated guidelines for reporting parallel group randomized trials, Ann Intern Med, 152, 726, 10.7326/0003-4819-152-11-201006010-00232